The Phase III Clinical Trial of X842 Capsules for Reflux Esophagitis

Clinical trial NCT07079540 · COMPLETED

Trial details

NCT number: NCT07079540
Sponsor: Jiangsu Sinorda Biomedicine Co., Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Reflux Esophagitis

Start date: 2021-06-24
Primary completion: 2022-07-27
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.